3-Cyclohexyl-2-methylenepropanoic acid | 131330-80-8

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 3-Cyclohexyl-2-methylenepropanoic acid
• 英文别名: 2-(Cyclohexylmethyl)prop-2-enoic acid
• CAS: 131330-80-8
• 化学式: C₁₀H₁₆O₂
• 分子量: 168.236
• InChiKey: VYYFUSCTNLUGPM-UHFFFAOYSA-N

物化性质

• 沸点：
  296.3±9.0 °C(Predicted)
• 密度：
  1.010±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.7
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-Cyclohexyl-2-methylenepropanoic acid 在 吡啶 、 草酰氯 作用下， 以 二氯甲烷 、 苯 为溶剂， 反应 3.5h， 生成
  参考文献：
  名称：

  New orally active enkephalinase inhibitors: their synthesis, biological activity, and analgesic properties

  摘要：

  A series of (4S)-4-[(2S)-benzyl-3-mercaptopropionylamino]-4-(N-phenylcarbamoyl)-butyric acids has been identified as potent systemically active enkephalinase inhibitors. Structure-activity relationships (SAR) are discussed. Further chemical modification of the inhibitors was carried out in order to identify the inhibitors which are orally active in an animal model. Compounds of particular interest are the prodrug-like analogues, including 5b (ONO-9902). Their analgesic effects after oral administration were evaluated. (C) 1998 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0968-0896(97)10048-7
• 作为产物：
  描述：

  ethyl 2-(cyclohexylmethyl)acrylate 在 氢氧化钾 作用下， 以 乙醇 为溶剂， 反应 1.5h， 生成 3-Cyclohexyl-2-methylenepropanoic acid
  参考文献：
  名称：

  New orally active enkephalinase inhibitors: their synthesis, biological activity, and analgesic properties

  摘要：

  A series of (4S)-4-[(2S)-benzyl-3-mercaptopropionylamino]-4-(N-phenylcarbamoyl)-butyric acids has been identified as potent systemically active enkephalinase inhibitors. Structure-activity relationships (SAR) are discussed. Further chemical modification of the inhibitors was carried out in order to identify the inhibitors which are orally active in an animal model. Compounds of particular interest are the prodrug-like analogues, including 5b (ONO-9902). Their analgesic effects after oral administration were evaluated. (C) 1998 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0968-0896(97)10048-7

文献信息

• [EN] LIGHT HARVESTING ARRAY<br/>[FR] RÉSEAU COLLECTEUR DE LUMIÈRE
  申请人：FLUROSOL IND PTY LTD

  公开号：WO2015024064A1

  公开（公告）日：2015-02-26

  The invention relates to a light harvesting array or dye comprising an acceptor linked to a donor, wherein at least one of the acceptor or the donor is an oligomeric unit comprising a first optionally substituted rylene linked via a linker group to a second optionally substituted rylene, the first optionally substituted rylene is linked to the acceptor or the donor and the second optionally substituted rylene is capable of energy transfer to at least one of the first optionally substituted rylene, the acceptor or the donor. The invention also relates to compounds which may be used as light harvesting arrays, methods for their manufacture, and devices and materials comprising the light harvesting array or dye, for example, chromophoric materials, light guides, photobioreactors, photoluminescent algae systems, photodetectors, photovoltaic devices and luminescent/fluorescent solar concentrators.

  该发明涉及一种光收集阵列或染料，包括一个与给体相连的受体，其中受体或给体中至少有一个是包含第一可选择取代的芳香烃单元通过连接基团连接到第二可选择取代的芳香烃的寡聚单元，第一可选择取代的芳香烃与受体或给体相连，第二可选择取代的芳香烃能够将能量传递至第一可选择取代的芳香烃、受体或给体中的至少一个。该发明还涉及可用作光收集阵列的化合物，其制造方法，以及包括光收集阵列或染料的设备和材料，例如，色素材料、光导管、光生物反应器、光致发光藻类系统、光探测器、光伏器件和发光/荧光太阳能聚光器。
• N-Formyl Hydrozyamine Compounds
  申请人：Lee Kwangho

  公开号：US20090062537A1

  公开（公告）日：2009-03-05

  Novel N-formyl hydroxylamine compounds and their derivatives are disclosed. These N-formyl hydroxylamine compounds inhibit peptidyl deformylase (PDF), an enzyme present in prokaryotes. The compounds are useful as antimicrobials and antibiotics. The compounds of the invention display selective inhibition of peptidyl deformylase versus other metalloproteinases such as MMPs. Methods of preparation and use of the compounds are also disclosed.

  本发明公开了新型N-甲酰基羟胺化合物及其衍生物。这些N-甲酰基羟胺化合物可以抑制肽脱甲酰酶（PDF），该酶存在于原核生物中。这些化合物作为抗菌素和抗生素具有用途。本发明的化合物对肽脱甲酰酶相对于其他金属蛋白酶如MMPs表现出了选择性抑制作用。还公开了这些化合物的制备方法和用途。
• [EN] ORGANIC SEMICONDUCTING COMPOUNDS<br/>[FR] COMPOSÉS SEMI-CONDUCTEURS ORGANIQUES
  申请人：MERCK PATENT GMBH

  公开号：WO2018065350A1

  公开（公告）日：2018-04-12

  The invention relates to novel organic semiconducting compounds containing apolycyclicunit, to methods for their preparation and educts or intermediates used therein, to compositions, polymer blends and formulations containing them, to the use of the compounds, compositions and polymer blends as organic semiconductors in, or for the preparation of, organic electronic (OE) devices, especially organic photovoltaic (OPV) devices, perovskite-based solar cell (PSC) devices, organic photodetectors (OPD), organic field effect transistors (OFET) and organic light emitting diodes (OLED), and to OE, OPV, PSC, OPD,OFET and OLED devices comprising these compounds, compositions or polymer blends.

  这项发明涉及含有多环单元的新型有机半导体化合物，涉及它们的制备方法和在其中使用的底物或中间体，涉及含有它们的组合物、聚合物混合物和配方，涉及将这些化合物、组合物和聚合物混合物用作有机半导体在有机电子（OE）器件中的使用，尤其是有机光伏（OPV）器件、钙钛矿太阳能电池（PSC）器件、有机光电探测器（OPD）、有机场效应晶体管（OFET）和有机发光二极管（OLED）的制备，以及包含这些化合物、组合物或聚合物混合物的OE、OPV、PSC、OPD、OFET和OLED器件。
• CURE ACCELERATORS FOR ANAEROBIC CURABLE COMPOSITIONS
  申请人：Henkel IP & Holding GmbH

  公开号：US20170174630A1

  公开（公告）日：2017-06-22

  Cure accelerators for anaerobic curable compositions, such as adhesives and sealants, are provided, and which are defined with reference to the compounds shown in structure I where A is CH 2 or benzyl, R is C 1-10 alkyl, R′ is H or C 1-10 alkyl, or R and R′ taken together may form a four to seven membered ring fused to the benzene ring, R″ is optional, but when R″ is present, R″ is halogen, alkyl, alkenyl, cycloalkyl, hydroxyalkyl, hydroxyalkenyl, alkoxy, amino, alkylene- or alkenylene-ether, alkylene (meth)acrylate, carbonyl, carboxyl, nitroso, sulfonate, hydroxyl or haloalkyl, and EWG is as shown, an electron withdrawing group, such as nitro, nitrile, carboxylate or trihaloalkyl.

  为氧化还原固化组合物（如胶粘剂和密封剂）提供了用于加速固化的固化催化剂，其定义参考结构I中显示的化合物，其中A为CH2或苄基，R为C1-10烷基，R′为H或C1-10烷基，或者R和R′一起可以形成与苯环融合的四至七元环，R″是可选的，但当R″存在时，R″是卤素、烷基、烯基、环烷基、羟基烷基、羟基烯基、烷氧基、氨基、烷基-或烯基-醚、烷基（甲基）丙烯酸酯、羰基、羧基、亚硝基、磺酸酯、羟基或卤代烷基，以及EWG如所示，是一种电子吸引基团，如硝基、腈基、羧酸盐或三卤代烷基。
• Palladium-Catalyzed Highly Regioselective Hydrocarboxylation of Alkynes with Carbon Dioxide
  作者：Wenfang Xiong、Fuxing Shi、Ruixiang Cheng、Baiyao Zhu、Lu Wang、Pengquan Chen、Hongming Lou、Wanqing Wu、Chaorong Qi、Ming Lei、Huanfeng Jiang

  DOI：10.1021/acscatal.0c01687

  日期：2020.7.17

  with high regioselectivity under mild reaction conditions. Experimental and DFT mechanistic studies revealed that this reaction proceeded via the cyclopalladation process of alkynes and carbon dioxide in the presence of binap to generate a five-membered palladalactone intermediate and enabled the formation of Markovnikov adducts. Moreover, this strategy provided an effective method for the late-stage

  已经建立了Pd催化的炔烃与二氧化碳的高度区域选择性加氢羧化反应。通过Pd（PPh 3）4的组合和2,2'-双（二苯基膦基）-1,1'-联萘（binap），可以利用各种功能化的炔烃，包括芳基炔烃，脂族炔烃，炔丙基胺和炔丙基醚，来提供多种α -丙烯酸在温和的反应条件下具有高的区域选择性和高收率。实验和DFT机理研究表明，该反应通过在binap存在下炔烃和二氧化碳的环palpalladation过程进行，生成五元的palladalactone中间体，并能够形成马尔可夫尼科夫加合物。此外，该策略为含炔烃的复杂分子（包括天然产物和药物）的后期功能化提供了有效的方法。